CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

February 7, 2024

https://www.globenewswire.com/news-release/2024/02/07/2825197/0/en/CervoMed-Announces-Appointment-of-Industry-Leader-Joshua-Boger-Ph-D-as-Chair-of-the-Board.html

Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals

CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies; topline data expected in 2H 2024

Read more at globenewswire.com

Related news for (CRVO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.